Results of phase I single dose study with NB-818, a new calcium channel blocker

Authors
Category Primary study
JournalJapanese Pharmacology and Therapeutics
Year 1992
This article has no abstract
Epistemonikos ID: f6d907b498d07b59148b59f9bdef04607f780302
First added on: Feb 03, 2025